NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
Global Childhood Cancer Access
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
Lenacapavir HIV Prevention: Approval and Access Strategy Updates
Genetic Testing in South Africa
PEPFAR Funding Pause Threatens Global HIV Progress
Healthcare at Home: CMC Dubai’s Innovative Program
Cost-Effective CML Treatment in South Africa
Trends in Endometrial Cancer Mortality
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
WHO Prequalifies First G6PD Diagnostic Test